Mineral Resources boss Chris Ellison's tenure at the head of the $10bn now has no end date, and it comes as lithium turns ...

EBR’s US launch is young, but early adoption and bullish broker upgrades are turning it into a medtech stock to watch.

China commands more than 90% of dysprosium and terbium supply, but Astron says Donald has the potential to reset that dynamic ...

Nvidia’s strong results reinforce the momentum behind AI, yet Nigel Green argues investors should stay disciplined.

Moving from developer to producer is a major milestone and these WA goldies are positioned to capitalise while prices are soaring.